Natalizumab: A New Treatment for Relapsing Remitting Multiple Sclerosis
Therapeutics and Clinical Risk Management - New Zealand
doi 10.2147/tcrm.2007.3.2.259
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2007
Authors
Publisher
Informa UK Limited